H-TPGPGVRYPL-OH

Ref. 3D-PP46388

Información del producto

• Nombre: H-TPGPGVRYPL-OH
• Sinónimos: NH2-Thr-Pro-Gly-Pro-Gly-Val-Arg-Tyr-Pro-Leu-OH

Descripción

Peptide H-TPGPGVRYPL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TPGPGVRYPL-OH include the following: Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection T Pillay, HT Zhang, JW Drijfhout, N Robinson - Journal of , 2005 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.79.18.12100-12105.2005 The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy T Bilich , A Nelde , L Bichmann - Blood, The Journal , 2019 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/133/6/550/260571 Cytotoxic T lymphocyte epitopes of HIV-1 Nef: generation of multiple definitive major histocompatibility complex class I ligands by proteasomes M Lucchiari-Hartz, PM Van Endert , G Lauvau - The Journal of , 2000 - rupress.orghttps://rupress.org/jem/article-abstract/191/2/239/50980 Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls F Gronen, K Ruprecht , B Weissbrich, E Klinker - Journal of , 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S016557280600333X HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokines CC Wilson , WC Olson, T Tuting, CR Rinaldo - The Journal of , 1999 - journals.aai.orghttps://journals.aai.org/jimmunol/article/162/5/3070/32311 Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion A Ascione, C Arenaccio, A Mallano, M Flego - BMC , 2019 - Springerhttps://link.springer.com/article/10.1186/s12896-019-0559-x

• Marca: Biosynth